A detailed history of Gsa Capital Partners LLP transactions in Icu Medical Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 7,808 shares of ICUI stock, worth $1.22 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
7,808
Previous 2,608 199.39%
Holding current value
$1.22 Million
Previous $310,000 359.03%
% of portfolio
0.11%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$114.88 - $182.17 $597,376 - $947,283
5,200 Added 199.39%
7,808 $1.42 Million
Q2 2024

Aug 15, 2024

BUY
$94.53 - $120.55 $246,534 - $314,394
2,608 New
2,608 $310,000
Q4 2023

Feb 16, 2024

BUY
$81.08 - $119.29 $398,670 - $586,548
4,917 New
4,917 $490,000
Q3 2022

Nov 14, 2022

BUY
$149.44 - $188.1 $541,720 - $681,862
3,625 New
3,625 $546,000
Q3 2021

Nov 12, 2021

SELL
$186.8 - $260.0 $258,157 - $359,320
-1,382 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$190.83 - $215.73 $263,727 - $298,138
1,382 New
1,382 $284,000
Q1 2021

May 10, 2021

SELL
$197.58 - $222.54 $344,381 - $387,887
-1,743 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$177.6 - $214.65 $44,044 - $53,233
248 Added 16.59%
1,743 $374,000
Q3 2020

Nov 06, 2020

BUY
$177.7 - $200.24 $265,661 - $299,358
1,495 New
1,495 $273,000
Q2 2019

Aug 06, 2019

SELL
$212.8 - $251.91 $766,080 - $906,876
-3,600 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$213.13 - $281.01 $1.52 Million - $2.01 Million
-7,141 Reduced 66.48%
3,600 $827,000
Q3 2018

Nov 13, 2018

BUY
$265.5 - $307.63 $1.07 Million - $1.24 Million
4,032 Added 60.1%
10,741 $3.04 Million
Q2 2018

Aug 09, 2018

BUY
$245.65 - $309.75 $1.65 Million - $2.08 Million
6,709 New
6,709 $1.97 Million

Others Institutions Holding ICUI

About ICU MEDICAL INC


  • Ticker ICUI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 23,899,400
  • Market Cap $3.75B
  • Description
  • ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...
More about ICUI
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.